Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
A new study has demonstrated that patients with advanced bladder cancers whose tumours have a…
Browsing: GU Cancers
EAU 2021: Nicotine by-product can predict recurrence of cancer
A by-product of nicotine, found in the urine of smokers, could be used to identify…
Exploiting urine RNAs as diagnostic markers of bladder cancer
Oncotarget published “Transcriptome analyses of urine RNA reveal tumor markers for human bladder cancer: validated…
Novel approach yields potential drug candidate for bladder cancer
A new approach to molecular drug design has yielded a highly promising bladder cancer drug,…
Study suggests blood test could guide precision treatment in bladder cancer
A blood test that can detect tiny amounts of circulating cancer DNA may be able…
The OJC Episode 38: ASCO 2021 GU Roundtable
The Oncology Journal Club Podcast Episode 38 In today’s special ASCO 2021 episode Craig Underhill…
Genitourinary Cancer Nurse Navigator looks for better outcomes for people with bladder cancer
PHD candidate Helen Anderson hopes her research will result in improved care and support for…
Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
A phase 3 clinical trial co-led by Mount Sinai researchers in the USA is the…
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line IO in advanced bladder cancer
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…